These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19717008)

  • 1. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
    Bright GM; Mendoza JR; Rosenfeld RG
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
    Richmond EJ; Rogol AD
    Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS).
    Park P; Cohen P
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S13-20. PubMed ID: 16039893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of recombinant insulin-like growth factor I in the treatment of the short child.
    Rosenbloom AL
    Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
    Collett-Solberg PF; Misra M;
    J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone-resistant syndromes: long-term follow-up.
    Chernausek SD
    Endocr Dev; 2009; 14():135-42. PubMed ID: 19293580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GH, IGF-I, and growth.
    Isaksson O
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1321-6. PubMed ID: 15506078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SomatoKine: is there a use in treating growth disorders?
    Kemp SF; Thrailkill KM
    Curr Opin Investig Drugs; 2005 Apr; 6(4):373-7. PubMed ID: 15898344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
    Clark RG
    Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.
    Backeljauw P
    Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():853-6. PubMed ID: 18438329
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone resistance in chronic heart failure and its therapeutic implications.
    Cicoira M; Kalra PR; Anker SD
    J Card Fail; 2003 Jun; 9(3):219-26. PubMed ID: 12815572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients.
    Petriczko E; Wikiera B; Horodnicka-Józwa A; Marcinkiewicz K; Szmit-Domagalska J; Kędzia A; Durzyńska J; Broniarczyk J; Gabryelczyk B; Noczyńska A; Walczak M
    Pediatr Endocrinol Diabetes Metab; 2011; 17(4):233-8. PubMed ID: 22248785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of insulin-like growth factor-I serum concentration as a screening procedure in diagnosing children with short stature.
    Smyczynska J; Lewinski A; Stawerska R; Hilczer M; Karasek M
    Neuro Endocrinol Lett; 2007 Jun; 28(3):274-8. PubMed ID: 17627261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
    Laron Z
    Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.
    Clark RG
    Pediatr Nephrol; 2005 Mar; 20(3):290-4. PubMed ID: 15682316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
    Midyett LK; Rogol AD; Van Meter QL; Frane J; Bright GM;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of growth hormone and insulin-like growth factor-I treatment in children with idiopathic short stature.
    Bang P
    Horm Res Paediatr; 2011; 76 Suppl 3():24-6. PubMed ID: 21912155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.